Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
1217769-52-2	Diltiazem-d4 (hydrochloride) CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl	C₂₂H₂₇ClN₂O₄S	455.0	-	Click to inquire
1246819-64-6	Levamisole-d5 Hydrochloride C1CSC2=NC(CN21)C3=CC=CC=C3.Cl	C₁₁H₁₃ClN₂S	245.78	95%	Click to inquire
134-36-1	Erythromycin propionate CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O	C₄₀H₇₁NO₁₄	790.0	≥90%	Click to inquire
1036959-23-5	(2S,2'S)-1,1'-(2,2'-((3-Hydroxyadamantan-1-yl)azanediyl)bis(acetyl))bis(pyrrolidine-2-carbonitrile) C1CC(N(C1)C(=O)CN(CC(=O)N2CCCC2C#N)C34CC5CC(C3)CC(C5)(C4)O)C#N	C₂₄H₃₃N₅O₃	439.6	≥90%	Click to inquire
565453-40-9	Vildagliptin Carboxylic Acid Metabolite C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C(=O)O	C₁₇H₂₆N₂O₄	322.4	≥90%	Click to inquire
1646355-34-1	7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione CC#CCN1C2=C(N=C1N(C)C)N(C(=O)N(C2=O)CC3=NC4=CC=CC=C4C(=N3)C)C	C₂₂H₂₃N₇O₂	417.5	≥90%	Click to inquire
1638744-06-5	N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin CC1=NC(=NC2=CC=CC=C12)CN3C(=O)C4=C(N=C(N4CC=C(C)Br)N5CCCC(C5)N)N(C3=O)C	C₂₅H₂₉BRN₈O₂	553.5	≥90%	Click to inquire
668273-74-3	Tert-butyl (s)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1h-purin-8-yl)piperidin-3-yl)carbamate CC#CCN1C2=C(N=C1N3CCCC(C3)NC(=O)OC(C)(C)C)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	C₃₀H₃₆N₈O₄	572.7	≥90%	Click to inquire
1283129-18-9	D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, 2,3,4,6-tetrakis(2,2-dimethylpropanoate), (1S)- CC1=C(C=C(C=C1)C2C(C(C(C(O2)COC(=O)C(C)(C)C)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C)CC3=CC=C(S3)C4=CC=C(C=C4)F	C₄₄H₅₇FO₉S	781.0	≥90%	Click to inquire
909-39-7	Opipramol dihydrochloride C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO.Cl.Cl	C₂₃H₃₁Cl₂N₃O	436.4	≥90%	Click to inquire

Diltiazem-d4 (hydrochloride)

Diltiazem-d4 Hydrochloride Also See: D460622 and D460624

C₂₂H₂₇ClN₂O₄S 455.0

Levamisole-d5 Hydrochloride

左旋咪唑-D5盐酸盐

C₁₁H₁₃ClN₂S 245.78

Erythromycin propionate

红霉素丙酸酯

C₄₀H₇₁NO₁₄ 790.0

(2S,2'S)-1,1'-(2,2'-((3-Hydroxyadamantan-1-yl)azanediyl)bis(acetyl))bis(pyrrolidine-2-carbonitrile)

维达列汀杂质2(非对映体混合物)

C₂₄H₃₃N₅O₃ 439.6

Vildagliptin Carboxylic Acid Metabolite

维达列汀羧酸代谢产物

C₁₇H₂₆N₂O₄ 322.4

7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

利格列汀杂质H

C₂₂H₂₃N₇O₂ 417.5

N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin

利格列汀杂质K

C₂₅H₂₉BRN₈O₂ 553.5

Tert-butyl (s)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1h-purin-8-yl)piperidin-3-yl)carbamate

利格列汀杂质S

C₃₀H₃₆N₈O₄ 572.7

D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, 2,3,4,6-tetrakis(2,2-dimethylpropanoate), (1S)-

(1S)-1,5-脱水-1-C-[3-[[5-(4-氟苯基)-2-噻吩基]甲基]-4-甲基苯基]-D-山梨糖醇 2,3,4,6-四(2,2-二甲基丙酸酯)

C₄₄H₅₇FO₉S 781.0

Opipramol dihydrochloride

C₂₃H₃₁Cl₂N₃O 436.4

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 801) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号